ALBA Industrial PhD student to be funded by Almirall

The ALBA Synchrotron in collaboration with the company Almirall and with the support of the Autonomous University of Barcelona (UAB) have submitted a grant proposal to the Catalan Government to hire one researcher to study drugs with synchrotron light techniques.

The ALBA Synchrotron and the pharmaceutical company Almirall together with the Autonomous University of Barcelona (UAB) have submitted a grant proposal to the Industrial Doctorates Plan of the Catalan Government for hiring one researcher student to be devoted to an Industrial project while performing PhD studies. The Industrial project will be focused on determining amorphous phase by Synchrotron X-ray Powder Diffraction on micronized drug substances. The PhD student will be funded by Almirall and to be hired by ALBA where the main part of the work will be carried out. Those interested in submitting their application must click this link and follow the instructions. Almirall is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. Almirall researches, develops, produces and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. This initiative confirms the contribution that ALBA can offer to the competitiveness of leading companies, like Almirall, and to the society, and it will also help to retain talent and to place doctoral students in companies where they can develop research and development projects.